Member Info for Mozax

Yes, you’re probably right, a 250K & 150K from 15:30 just printed now.

Mr Buffett would say it’s an opportunity.

Rory & Chris won’t be best pleased, they hold 42%.

There’s still a big seller, 350K dumped in 2 trades at 15:30.

I’ll wait and see how low this goes before adding further.

Then switch off and leave it 12 months.

Pretty gruesome sell off.

I’ve taken 200K at 1.138 at 13:10.

I rode ARB on the first rally back in Jan/Feb/March 2021 & re bought before Xmas on the first mini-rally up to 4p.

Sentiment is returning to the sector, Inflation & Fiat currencies being hammered will assist Gold & BTC I believe.

The options here announced on 20th December exercisable at 5 & 10p is interesting.

I have a feeling these will be worth holding onto, especially at these prices.

Will focus attention here.

Good post Portfolio power, I’m in agreement with you, I think OMI could provide some hefty returns.

I first bought ARB back in November 2020 at around 6p.
BTC, as I recall, was around $14K.

I posted a fair bit around December 2020 through to Feb before and into the epic rise, and due to the phenomenal rise i gradually scaled out, and made a good deal of money.
Some was removed from my ISA to pay off debt, some was reinvested elsewhere, poorly, in the majority of cases, with some investments over 70% down.

However, I’ve started to buy back in here again.

Call it a gut feeling.

Lightening may not strike twice, but by heck, I wouldn’t want to miss it if it did.

There are numerous examples of Companies having enormous valuations that don’t turn a profit.

Tech Companies especially.

Whilst opinions are welcome one must also recognise that there are many factors that contribute to a Company Valuation.

Being best in class, first mover advantage, heavily patented, Global reach & scalability are a few to start off with.

Having a high staff wage roll is relevant to the World class product in manufacture, and now, subsequent traction & rollout.

Clever update.

Released whilst the market is quiet so it can be digested over the next few days and prior to the market getting going properly in The New Year. In 2023.

As I mentioned before, 2023 will be a game changer , ( Gamesa changer ….too) and with the small stock issue in circulation expect significant uplift in share price.

This was sold down in the tech sell off, but realisation that this is a tech Company in exactly the right space, with the right product, at the right time, and the turnaround will be tremendous.

Sales receipts are going to be ‘significantly ahead’ of expectations.

Any investor rather likes that phrase.

Has broken $1800 convincingly.

If this is the start of a proper Gold Rally, then this will rise significantly without any news.

My view is that the order book has grown very nicely since share price all time lows, and the quality of the Companies who have placed those orders is significant.

2023 will be a game changer for IES, there’s an incredible amount going on in numerous jurisdictions around the Globe plus it is the year of the launch of ‘Mistral’.

Whilst I anticipate we have over £10M in cash currently the Company has arranged a facility for further working capital, to deliver orders & have security in place for an expected surge in further orders.

When a Company is growing quickly, cash is critical.

Potentially very large upside from these levels for the patient.

The fact that Nuformix has applied for 2 Patents with potential protection out to 2041 is encouraging.

Plenty of Work to do but holding even a small amount for potential commercialisation may prove to be quite an investment.

Red day across the markets but give this a bit of time, I’m going to add more.

Volume suddenly 22.5 Million.

I have L2, and the evidence is flooding in.

Something is up, flood of buys incoming.

£60K buy supports my theory, just printed.

Behind us, and talk of moving into profitability in that RNS.

Taiwanese potential order of 225MWh would put the cat amongst the pigeons.

Seems to be up this morning.

Suggest they are making the most of the discount.

Will just see this as an opportunity to add further.

The reference price for the note holders is 44.7p but they are exercisable at 67.35p each.

If this does dip to 44p expect a good bounce again.

The funding is done now, let’s see what other news will be announced.

Opportunity to add more for those thinking they’d missed the boat.

Invinity was sold down to an unprecedented level and the recent rise is both subject to a correction plus a total change in sentiment given the numerous orders, and potential for huge follow on orders.

There will be traders tempted to try to profit from a re-trace, and may have opened a Short.

These traders will always talk the stock down as it’s in their interest.

Good luck with that.